Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mycophenolate (CellCept) (1 trial)
sirolimus (rapamune) (1 trial)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetic Nephropathies (Phase 3)
Trials (1 total)
Trial APIs (2 total)